 |
Accelerated COVID-19 vaccine development – A testament to scientific advancement and institutional collaborations September 2021 |
3.5MB |
Archive
|
China’s policy overhauls: What does this mean for pharmaceutical approvals? June 2020 |
3.0MB |
|
Market access challenges of advanced therapy medicinal products January 2018 |
2.0MB |
|
Impact of 2017 policy changes on China’s pharmaceutical market January 2018 |
5.0MB |
